Home » Topics » BioWorld Science, Dermatologic

BioWorld Science, Dermatologic
RSS

ADCON-L and ADCON-T/N research demonstrates efficacy

Aug. 30, 1996

Treatment for keratinization disorders described by Janssen

Aug. 30, 1996

Sepracoat given European Approval of Conformity Certificate

Aug. 30, 1996

Repel proved effective in preclinical studies

Aug. 23, 1996

Genzyme's Seprafilm approved by FDA

Aug. 23, 1996

Kanebo and Ontogen to codevelop cell adhesion factor inhibitor

Aug. 23, 1996

Dusa completes phase IIb for ALA PDT

Aug. 23, 1996

Dyad granted U.S. patent for oligonucleotides

Aug. 23, 1996

Protein Polymer Technologies and Ethicon sign R&D agreement

Aug. 23, 1996

Microsponge retinol system to be codeveloped by APS and Avon

Aug. 16, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 30, 2026.
Emerging therapeutic strategies for Parkinson’s at ADPD 2026
BioWorld
Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
With improved technologies, biomarkers, failed drugs may come into their own
BioWorld
At BioEurope Spring 2026, pharma representatives and investors shared their thoughts about current and future landscapes of different disease areas, and on how to...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 24, 2026